Click image to enlarge
The
U-PLEX platform offers validated components that can be combined to create high quality assays quickly and easily. The U-PLEX Mouse MCP-1 Antibody Set is a matched pair of antibodies that can be used (with other U-PLEX components such as plates, calibrators, diluents, and MSD GOLD Read Buffer B) to build U-PLEX assays that measure MCP-1. These assays can measure MCP-1 alone or in multiplex panels with other biomarkers. The Product Inserts in the “Documentation” tab (below) provide detailed instructions for building assays with U-PLEX Antibody Sets.
For information on multiplexing MCP-1 with other analytes, please see
U-PLEX Biomarker Group 1 or
Metabolic Group 1 Mouse Assays.
-
-
Specifications
-
Kit Contents
-
-
Documentation
-
References
|
Analyte(s)
|
|
MCP-1
|
|
|
Species
|
|
Mouse
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
|
Storage Condition
|
|
2-8 °C
|
|
|
Gene ID(s)
|
|
20296
|
|
|
UniProt ID(s)
|
|
P10148
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Biotin Mouse MCP-1 Antibody, 1 Plate Size
|
2-8 °C
|
1 vial
(1 plate size)
|
|
|
|
SULFO-TAG Mouse MCP-1 Antibody, 1 Plate Size
|
2-8 °C
|
1 vial
(1 plate size)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Biotin Mouse MCP-1 Antibody, 5 Plate Size
|
2-8 °C
|
1 vial
(5 plate size)
|
|
|
|
SULFO-TAG Mouse MCP-1 Antibody, 5 Plate Size
|
2-8 °C
|
1 vial
(5 plate size)
|
|
|
|
Product Inserts
|
|
|
|
Datasheets
|
|
|
|
Product Highlights
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses
|
|
|
|
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial
|
|
|
|
CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer’s disease
|
|
|
|
Kinetics and Biomarkers of Severe Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor-modified T Cell Therapy.
|
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters